SEC Comment Letter 0000000000-24-001365 to Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc.
Date: Feb. 5, 2024 · CIK: 0001707502 · Accession: 0000000000-24-001365
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276764
Letter
United States securities and exchange commission logo February 5, 2024 Alexander Cumbo Chief Executive Officer Solid Biosciences Inc. 500 Rutherford Avenue, Third Floor Charlestown, MA 02129 Re:Solid Biosciences Inc. Registration Statement on Form S-3 Filed January 30, 2024 File No. 333-276764 Dear Alexander Cumbo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Caroline Dotolo, Esq.
Show Raw Text
United States securities and exchange commission logo
February 5, 2024
Alexander Cumbo
Chief Executive Officer
Solid Biosciences Inc.
500 Rutherford Avenue, Third Floor
Charlestown, MA 02129
Re:Solid Biosciences Inc.
Registration Statement on Form S-3
Filed January 30, 2024
File No. 333-276764
Dear Alexander Cumbo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Caroline Dotolo, Esq.